Sign Up to like & get recommendations! 2
Published in 2023 at "British journal of haematology"
DOI: 10.1111/bjh.18825
Abstract: Hyperhaemolysis syndrome (HHS), a severe form of delayed haemolytic transfusion reaction most commonly described in patients with sickle cell disease (SCD), involves destruction of both donor and recipient red blood cells (RBCs). As the epidemiology… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Transfusion"
DOI: 10.1111/trf.17066
Abstract: Patients with refractoriness to platelet transfusion due to antibodies against Class I human leukocyte antigens (HLA) found on platelets, often need HLA-compatible platelets. These products are either matched to the patient's HLA type or selected… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Transfusion"
DOI: 10.1111/trf.17800
Abstract: Red blood cell (RBC) antibodies are common in multiply transfused patients with sickle cell disease (SCD). Unlike RBC alloantibodies, the potential of autoantibodies to cause post‐transfusion hemolysis may be uncertain. Biotin‐labeling provides a direct measurement… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Transfusion"
DOI: 10.1111/trf.17879
Abstract: Platelet radiolabeling with radioisotopes is currently used for human platelet recovery and survival studies. Biotinylation enables ex vivo post‐transfusion platelet function testing. Whether platelet biotinylation itself affects platelet function is controversial. read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Veterinary Clinical Pathology"
DOI: 10.1111/vcp.13379
Abstract: Abstract Background Packed RBC (pRBC) transfusions are often necessary to enhance organ perfusion and tissue oxygenation in cases of severe anemia. Objectives We aimed to describe changes in acid–base and biochemical parameters in dogs after… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Vox Sanguinis"
DOI: 10.1111/vox.13381
Abstract: Immune‐mediated acute or delayed transfusion reactions occur when there is immunological incompatibility between transfused blood products and recipient's antibodies. Acute haemolytic transfusion reactions occur within 24 h and are delayed after 24 h up to 10 days following… read more here.
Sign Up to like & get recommendations! 0
Published in 2025 at "BMJ Case Reports"
DOI: 10.1136/bcr-2025-265158
Abstract: Post-transfusion purpura (PTP) is a rare, immune-mediated disorder characterised by severe thrombocytopaenia occurring 5–12 days after a blood transfusion. It occurs in approximately from 1 out of 24 000 to 1 out of 100 000 transfusions. It… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Feline Medicine and Surgery"
DOI: 10.1177/1098612x221094502
Abstract: Objectives The aim of this study was to characterize anti-feline erythrocyte antigen (FEA) 1 alloantibodies following sensitization of FEA 1-negative cats, including their rate of appearance, agglutination titer over time and immunoglobulin class. A secondary… read more here.
Sign Up to like & get recommendations! 0
Published in 2024 at "Blood"
DOI: 10.1182/blood-2024-205237
Abstract: Thrombocytopenia affects 22-35% of all neonates admitted to the neonatal intensive care unit (NICU), and prophylactic platelet transfusions are administered to thrombocytopenic premature neonates at higher platelet count thresholds than used in children/adults in an… read more here.